Skip to main navigation Skip to search Skip to main content

Synbiotics: Promising Approach for the Therapeutic Management of Cancer

  • Yinghan Chan
  • , Joycelin Zhu Xin Tan
  • , Xin Wei Lim
  • , Dinesh Kumar Chellappan
  • , Kamal Dua
  • International Medical University
  • University of Manchester
  • University of Technology Sydney

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Cancer represents a wide range of diseases that could begin in any parts of the body when cells grow abnormally and uncontrollably exceeding their normal boundaries. Cancer is a major health concern as statistics have shown that it is the second leading cause of death around the world. Treating cancer is a highly challenging and complex process. In addition to conventional therapeutic approaches such as chemotherapy, radiotherapy, and surgery, advances in oncology research over the recent years have led to the development of modern therapeutic approaches including stem cell therapy, sonodynamic therapy, ablation therapy, and chemodynamic therapy. Nonetheless, due to its increasing prevalence and growing burden on individuals, communities, and global health systems, a constant search for novel and efficient therapeutics is necessary to improve the overall survival and well-being of the affected population, as well as to alleviate critical adverse effects associated with the use of anticancer therapeutics. For this instance, the human gut microbiota has a strong influence on human homeostasis in which numerous studies have proven that maintaining a healthy gut could prevent diseases while ameliorating various pathological conditions. As the gut microbiota evolves throughout the entire life of the host as a direct consequence of lifestyle habits of an individual, synbiotics are one of the best evidenced means of manipulating the gut microbiota for therapeutic benefits. Generally, synbiotic products contain one or more combinations of probiotics and prebiotics which could confer health benefit on the host by improving the survival of live microbials in the gastrointestinal tract through selective growth induction, as well as activation of metabolism of one or more health-promoting bacteria, thereby restoring normal gut bacterial flora. In this chapter, we discuss some of the possible anticancer properties of synbiotics and highlight several studies performed in this field of research, which could potentially justify the utilization of synbiotics in cancer prevention and therapy.

Original languageEnglish
Title of host publicationSynbiotics for the Management of Cancer
PublisherSpringer Nature
Pages61-98
Number of pages38
ISBN (Electronic)9789811975509
ISBN (Print)9789811975493
DOIs
StatePublished - 1 Jan 2023
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Anti-inflammatory
  • Anti-oxidative
  • Anticancer
  • Gut microbiota
  • Immunomodulatory
  • Synbiotics

Fingerprint

Dive into the research topics of 'Synbiotics: Promising Approach for the Therapeutic Management of Cancer'. Together they form a unique fingerprint.

Cite this